查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649405

大容量腸外藥物市場 - 預測至 2025 年至 2030 年

Large Volume Parenteral Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

大容量腸外藥物市場預計將以 5.05% 的複合年成長率成長，從 2025 年的 123.85 億美元達到 2030 年的 158.43 億美元。

大容量腸外注射劑 (LVP) 是靜脈注射的體積大於 100 毫升（最多 2000 毫升）的無菌溶液。這些溶液（例如氯化鈉、葡萄糖、林格氏溶液、乳酸林格氏溶液）對於補水、電解質平衡、營養支持和快速藥物給藥至關重要，尤其是在外科和慢性病護理環境中。

市場促進因素

  • 慢性病負擔：全球需要住院治療的疾病（如癌症、糖尿病、腎臟病）的盛行率正在增加。
  • 外科手術數量不斷增加：市場擴張是由外科手術數量不斷增加所推動的，其中 LVP 對於麻醉、補液和術後護理至關重要。
  • 藥物傳遞的進展：LVP 可以實現高效持續給藥，例如用於癌症疼痛管理的氫可酮，滿足單劑量治療和簡化治療通訊協定的需求。

地理見解

  • 北美引領市場，得益於強大的醫療保健基礎設施和高發生率的慢性疼痛疾病。例如，美國癌症協會預測，2024 年美國將有 2,001,140 例新癌症病例和 611,720 例死亡病例，支持了 LVP 在疼痛管理方面的需求。
  • 。該地區不斷成長的手術量和對先進液體替代療法的重視進一步鞏固了其地位。

這一成長反映了 LVP 在現代醫療保健中發揮的重要作用，以精確性和擴充性滿足了急性護理需求和長期治療需求。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 適合廣泛用戶：對於新興企業、科學研究機構、顧問公司、中小企業和大型企業來說都是有益且具成本效益的。

它有什麼用途？

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的歷史資料與預測
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 各細分市場及各地區（包括國家）的收益成長及預測分析
  • 公司概況（尤其是關鍵發展）

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

5. 大劑量腸外藥物市場（以數量計算）

  • 介紹
  • 100ml-250ml
  • 250ml-500ml
  • 500毫升以上

第6章 大容量腸外藥物市場（依應用）

  • 介紹
  • 糾正電解質和液體失衡
  • 營養
  • 用於給藥其他藥物的車輛

7. 大劑量注射用藥物市場（依包裝類型）

  • 介紹
  • 糾正電解質和液體失衡
  • 營養
  • 用於給藥其他藥物的車輛

8. 大宗腸外藥物市場（按地區）

  • 介紹
  • 北美洲
    • 按數量
    • 按應用
    • 按包裝容器
    • 按國家
  • 南美洲
    • 按數量
    • 按應用
    • 按包裝容器
    • 按國家
  • 歐洲
    • 按數量
    • 按應用
    • 按包裝容器
    • 按國家
  • 中東和非洲
    • 按數量
    • 按應用
    • 按包裝容器
    • 按國家
  • 亞太地區
    • 按數量
    • 按應用
    • 按包裝容器
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Fresenius Kabi AG
  • Albert David Ltd.
  • Otsuka Holdings Co., Ltd.
  • Grifols SA
  • B. Braun Melsungen AG
  • BML Parenteral Drugs
  • Akums Drugs & Pharmaceuticals Ltd.
  • DJ Labs
  • Parenteral Drugs（India）Limited
  • BKRS Pharma Pvt. Ltd.
  • Pfizer.
  • Baxter.
  • August Services
  • INCOG BioPharma Services
  • Simtra BioPharma Solutions
簡介目錄
Product Code: KSI061613637

The large volume parenteral market is expected to grow at a CAGR of 5.05%, reaching a market size of US$15.843 billion in 2030 from US$12.385 billion in 2025.

Large volume parenterals (LVPs) are sterile solutions administered intravenously in volumes exceeding 100 mL (ranging up to 2000 mL). These solutions-such as sodium chloride, dextrose, Ringer's, and lactated Ringer's-are critical for fluid replacement, electrolyte balance, nutrition, and rapid medication delivery, particularly in surgical and chronic care settings.

Market Drivers

  • Chronic Disease Burden: Rising global prevalence of conditions requiring hospitalization (e.g., cancer, diabetes, renal disorders) fuels demand for LVPs in fluid and nutrient therapy.
  • Surgical Volume Growth: Increasing surgical procedures, where LVPs are essential for anesthesia, hydration, and post-operative care, drive market expansion.
  • Advancements in Drug Delivery: LVPs enable efficient, continuous administration of medications like morphine for cancer pain management, aligning with the demand for single-dose therapies and streamlined treatment protocols.

Geographical Insights

  • North America leads the market, supported by robust healthcare infrastructure and high rates of chronic pain conditions. For example, the American Cancer Society projects 2,001,140 new cancer cases and 611,720 deaths in the U.S. in 2024, underscoring the need for LVPs in pain management.
  • The region's growing surgical volumes and emphasis on advanced fluid replacement therapies further solidify its dominance.

This growth reflects LVPs' pivotal role in modern healthcare, bridging acute care needs with long-term therapeutic demands through precision and scalability.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The large volume parenteral market is segmented and analyzed as follows:

By Volume

  • 100 ml - 250 ml
  • 250 ml - 500 ml
  • Above 500 ml

By Application

  • Correction of electrolyte & fluid balance disturbances
  • Nutrition
  • Vehicle for administering other drugs

By Packaging Container

  • Glass Bottle
  • Plastic Bags

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. LARGE VOLUME PARENTERAL MARKET BY VOLUME

  • 5.1. Introduction
  • 5.2. 100 ml - 250 ml
  • 5.3. 250 ml - 500 ml
  • 5.4. Above 500 ml

6. LARGE VOLUME PARENTERAL MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Correction of electrolyte & fluid balance disturbances
  • 6.3. Nutrition
  • 6.4. Vehicle for administering other drugs

7. LARGE VOLUME PARENTERAL MARKET BY PACKAGING CONTAINER

  • 7.1. Introduction
  • 7.2. Correction of electrolyte & fluid balance disturbances
  • 7.3. Nutrition
  • 7.4. Vehicle for administering other drugs

8. LARGE VOLUME PARENTERAL MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Volume
    • 8.2.2. By Application
    • 8.2.3. By Packaging Container
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Volume
    • 8.3.2. By Application
    • 8.3.3. By Packaging Container
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Volume
    • 8.4.2. By Application
    • 8.4.3. By Packaging Container
    • 8.4.4. By Country
      • 8.4.4.1. UK
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Volume
    • 8.5.2. By Application
    • 8.5.3. By Packaging Container
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Israel
      • 8.5.4.3. Saudi Arabia
      • 8.5.4.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Volume
    • 8.6.2. By Application
    • 8.6.3. By Packaging Container
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Fresenius Kabi AG
  • 10.2. Albert David Ltd.
  • 10.3. Otsuka Holdings Co., Ltd.
  • 10.4. Grifols S.A.
  • 10.5. B. Braun Melsungen AG
  • 10.6. BML Parenteral Drugs
  • 10.7. Akums Drugs & Pharmaceuticals Ltd.
  • 10.8. DJ Labs
  • 10.9. Parenteral Drugs (India) Limited
  • 10.10. BKRS Pharma Pvt. Ltd.
  • 10.11. Pfizer.
  • 10.12. Baxter.
  • 10.13. August Services
  • 10.14. INCOG BioPharma Services
  • 10.15. Simtra BioPharma Solutions